Drug development program started based on CAP Human Cell Line
New platform may provide solutions for many RA-patients around the world
05-Mar-2009 -
Alloksys Life Sciences BV, CEVEC Pharmaceuticals GmbH and PharmaCell BV announced the start of Theraptech, a 2.4 million Euro therapeutic protein development program subsidized under the European Trans Bio Program.
The major objective of the Theraptech project is to develop a recombinant human ...
cell lines
clinical trials
diseases
+7